Enzymes such as branched-chain amino acid transaminase 1 (BCAT1) are upregulated in NSCLC and have been associated with tumor aggressiveness and poor clinical outcomes (63). This evidence concerns the gene BCAT1 and non-small cell lung carcinoma.